Skip to main content

Table 1 Inclusion and exclusion criteria

From: Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect)

Patients with confirmed Lyme borreliosis
Inclusion criteria:
 • Patients ≥18 years with confirmed proven or probable early localized or disseminated Lyme borreliosis manifestation as specified in Additional file 1: Table S1;
 • In case of an EM reported at, the EM has been present < 3 months and the clinical diagnosis has been confirmed by the general practitioner (criteria for clinical diagnosis are described in Additional file 1: Table S1);
 • Subjects live or stay on the mainland of the Netherlands.
Exclusion criteria:
 • Subjects unable to provide informed consent or not having a sufficient command of the Dutch language;
 • Subjects who started antibiotic treatment > 4 days before inclusion (for subjects included through the website or > 7 days before inclusion (for subjects included through the clinical expert centers for Lyme borreliosis);
 • Subjects who have ongoing signs or symptoms attributed to a previous episode of Lyme borreliosis.
Patients with unconfirmed Lyme borreliosis
Inclusion criteria:
 • Myalgia, arthralgia, neuralgia, concentration disorders, cognitive disturbances, with or without fatigue, present for ≥6 months at baseline
 • Severity of symptoms assessed by the CIS, SF-36 and/or CFQ questionnaire above the Dutch norm scores;
 • Subjects have a negative serological test for B. burgdorferi s.l. (IgG ELISA or C6 IgM/IgG ELISA), but have a history of an unconfirmed suspicion of Lyme disease, based on
  • a positive result for a non-recommended diagnostic test (e.g., cellular tests, CD57 analysis, viable blood analysis, bioresonance), or
  • onset of disease symptoms that have started within one month after a documented tick bite.
Exclusion criteria:
 • Subjects are unable to give informed consent or do not have sufficient command of the Dutch language.